Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanodelivery systems for cutaneous melanoma treatment

European Journal of Pharmaceutics and Biopharmaceutics(2023)10.1016/j.ejpb.2023.02.002Source: DataRank Database

Nanodelivery systems for cutaneous melanoma treatment is a research paper published in European Journal of Pharmaceutics and Biopharmaceutics (2023). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: hybridTopics (20)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Carina Monteiro,Miguel Pereira‐Silva ORCID,Diana Peixoto ORCID,Cláudia Nunes ORCID,Salette Reis ORCID

Live enrichment

PubMed:36773725

Fundação para a Ciência e a Tecnologia

Grant: SFRH/BD/136892/2018

Novo: Exploring innovative nanodelivery systems for melanoma photodynamic therapyInicial: Halloysite clay nanotubes as a technological innovation platform for melanoma combined gene and photodynamic therapies

Fundação para a Ciência e a Tecnologia

Grant: SFRH/BD/148771/2019

Red blood cell-pancreatic cancer hybrid membrane-camouflaged vitamin E derivatives-based nanoparticles for homotypic targeted co-delivery of paclitaxel and gemcitabine to fight pancreatic cancer

National Institutes of Health

Grant: R01AI050875

National Institutes of Health

Grant: R21AI121700

hybridLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.ejpb.2023.02.002

publisherhttps://api.elsevier.com/content/article/PII:S0939641123000346?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0939641123000346?httpAccept=text/plain

https://pubmed.ncbi.nlm.nih.gov/36773725

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansMelanomaSkin NeoplasmsAdministration, CutaneousNanoparticle Drug Delivery SystemCutaneous Malignant Melanoma

Keywords

MelanomaNanotechnologyAdministration routePreclinical ResearchHuman Clinical TrialsPatent ClaimsSkin NeoplasmsCutaneous Malignant MelanomaHumansNanoparticle Drug Delivery SystemAdministration, Cutaneous